Lieve Verplancke
Direktor/Vorstandsmitglied bei MATERIALISE NV
Vermögen: - $ am 30.04.2024
Aktive Positionen von Lieve Verplancke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MATERIALISE NV | Direktor/Vorstandsmitglied | 09.06.2015 | - |
Independent Dir/Board Member | 09.06.2015 | - | |
MDXHEALTH SA | Direktor/Vorstandsmitglied | 26.05.2017 | - |
Independent Dir/Board Member | 26.05.2017 | - | |
Fondation contre le Cancer | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lieve Verplancke
Ehemalige bekannte Positionen von Lieve Verplancke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Qaly-Co BV | Gründer | 01.01.2013 | 01.01.2020 |
Corporate Officer/Principal | 01.01.2013 | 01.01.2020 | |
Qaly | Vorstandsvorsitzender | 01.01.2013 | 01.01.2020 |
Gründer | 01.01.2013 | 01.01.2020 | |
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Corporate Officer/Principal | - | 01.01.2012 |
Stichting Tegen Kanker | Direktor/Vorstandsmitglied | - | - |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Imelda Hospital | Direktor/Vorstandsmitglied | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Lieve Verplancke
Katholieke Universiteit Leuven | Doctorate Degree |
University of Antwerp | Graduate Degree |
Statistik
International
Belgien | 13 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
MDXHEALTH SA | Health Technology |
MATERIALISE NV | Technology Services |
Private Unternehmen | 8 |
---|---|
Euronext Brussels SA/NV
Euronext Brussels SA/NV Investment Banks/BrokersFinance Euronext Brussels SA/NV operates a stock exchange. It provides services for regulated stock and derivatives markets in Belgium. The company also offers services, such as facilitating public offerings, providing trading facilities for cash & derivatives products and supplying market data. Euronext Brussels was founded in 1801 and is headquartered in Brussels, Belgium. | Finance |
Quest for Growth NV
Quest for Growth NV Investment ManagersFinance Quest for Growth NV, a fund traded on Euronext Brussels, has a diversified portfolio which is invested in growth companies listed on European stock exchanges, in European unquoted companies and in venture capital funds. It focuses on innovative companies in areas such as digital technologies (ICT), technologies for the healthcare sector (Health-tech) and clean technology (Cleantech). | Finance |
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Health Technology |
Stichting Tegen Kanker | Miscellaneous |
Qaly | |
Imelda Hospital | |
Fondation contre le Cancer | Miscellaneous |
Qaly-Co BV |
- Börse
- Insiders
- Lieve Verplancke
- Erfahrung